Tower Research Capital LLC (Trc) Nls Pharmaceutics Ltd. Transaction History

Tower Research Capital LLC (Trc)

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.92 - $1.56 $92 - $156	100 New	100 $0
Q4 2022 Feb 10, 2023	BUY	$0.48 - $1.29 $48 - $129	100 New	100 $0
Q2 2022 Aug 15, 2022	SELL	$0.53 - $1.36 $1,942 - $4,984	-3,665 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$0.82 - $1.76 $3,005 - $6,450	3,665 New	3,665 $5,000
Q2 2021 Aug 16, 2021	SELL	$2.91 - $4.12 $106,287 - $150,483	-36,525 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.28 - $5.85 $83,277 - $213,671	36,525 New	36,525 $148,000

Ticker NLSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,349,900
Market Cap $55.5M
Description
NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, suc...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.